BIOMAT Database Logo BIOMAT Database Logo

[Preliminary results with a new oral antidiabetic drug of the sulfanylurea series: glibenclamide or HB 419]. 1970

F Marocco, and G Patrito

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003510 Cyclohexanes Six-carbon alicyclic hydrocarbons.
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

F Marocco, and G Patrito
Glibenclamide (HB 419): a new oral antidiabetic of sulphonylurea type.
August 1969, German medical monthly,
F Marocco, and G Patrito
[Clinical experiences with oral antidiabetic HB 419 (glibenclamide)].
August 1969, Arzneimittel-Forschung,
F Marocco, and G Patrito
[Clinical trial of a new antidiabetic active by oral route: glibenclamide or HB 419 Hoechst].
February 1970, Revue medicale de Liege,
F Marocco, and G Patrito
Clinical investigations of the efficacy of the new oral antidiabetic agent glibenclamide (HB 419).
August 1969, German medical monthly,
F Marocco, and G Patrito
A clinical evaluation of glibenclamide (HB 419, "Daonil") a new antidiabetic sulphonylurea.
April 1972, Singapore medical journal,
F Marocco, and G Patrito
[Antimicrobial effect of the new oral antidiabetic HB 419].
August 1969, Arzneimittel-Forschung,
F Marocco, and G Patrito
[HB 419, a new oral antidiabetic; administration to the aged].
September 1969, Wiener medizinische Wochenschrift (1946),
F Marocco, and G Patrito
[Pharmacology of HB 419, a new strongly effective oral antidiabetic].
August 1969, Arzneimittel-Forschung,
F Marocco, and G Patrito
[Clinical study of a new hypoglycemic sulfamide: glibenclamide or HB 419].
November 1969, Lyon medical,
F Marocco, and G Patrito
[Effect of HB 419--a new oral antidiabetic--on fat metabolism].
August 1969, Arzneimittel-Forschung,
Copied contents to your clipboard!